Latest Regulatory News

Avira Resources has validated significant high-grade gold intersections at its Mt Cattlin Gold Project, underpinning plans for a maiden Mineral Resource Estimate by the end of 2026. The company is poised to commence drilling in Q2 to test extensions across multiple prospects.

Emyria Limited is on track to open its first Empax clinic in Victoria by Q2 2026, having secured key operational milestones including a trained clinical workforce and dual reimbursement pathways.

Latrobe Magnesium Limited has successfully produced around 20 tonnes of high-grade Magnesium Oxide from its Hazelwood North Demonstration Plant, paving the way for magnesium metal production later this year.

BlinkLab has enrolled its first participant in the pivotal FDA 510(k) validation study for its autism diagnostic aid, BlinkLab Dx1, aiming for regulatory submission by the end of 2026.

Radiopharm Theranostics reports promising second interim Phase 2b results for RAD 101, showing 90% concordance with MRI in detecting brain metastases and encouraging sensitivity and specificity trends.

dorsaVi has commenced development of Sensor V6.5, a firmware upgrade that embeds intelligence directly within its wearable sensors, reducing latency and paving the way for future neuromorphic computing integration.

Echo IQ has strengthened its partnership with Mayo Clinic to distribute its AI-driven heart failure diagnostic tool, EchoSolv HF, pending FDA clearance. The expanded agreement offers a scalable commercial pathway across a vast US hospital network.

Latitude Group Holdings Limited has launched an offer to raise approximately $100 million through Capital Notes 2, a new series of perpetual, subordinated, unsecured convertible notes. Existing Capital Notes 1 holders are invited to reinvest in the new notes, which feature discretionary quarterly distributions and potential conversion to ordinary shares.

Amaero Ltd has amended its scheme implementation deed, revising the consideration offered to option holders as it progresses with its re-domiciliation from Australia to the US. Key milestones for the transition are scheduled through mid-2026.

Clover Corporation has reported a robust first half for FY26, with revenue climbing 17% and margins expanding significantly, underpinning a confident revenue forecast for the full year.

SQX Resources has addressed an ASX compliance query regarding director Bevan Tarratt’s trading during a closed period, confirming prior board approval and an administrative disclosure error.

ActivEX Limited has raised nearly $400,000 through a strategic placement of shares at a slight premium, locking in investor support with a 12-month escrow. The funds aim to fuel ongoing exploration efforts and bolster working capital.